Sweden
Tuberculosis profile
Population  2013 9.6 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.013 (0.013–0.013) 0.14 (0.13–0.14)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.01 (0.01–0.02)
Prevalence  (includes HIV+TB) 0.86 (0.35–1.6) 9 (3.7–17)
Incidence  (includes HIV+TB) 0.69 (0.64–0.75) 7.2 (6.7–7.9)
Incidence (HIV+TB only) 0.01 (<0.01–0.011) 0.11 (0.05–0.12)
Case detection, all forms (%) 88 (81–95)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 1.8 (0.59–4.2) 13 (1.6–38)
MDR-TB cases among notified pulmonary
TB cases
6 (2–14) 5 (1–15)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 308   1
Pulmonary, clinically diagnosed 39   0
Extrapulmonary 258   4
       
Total new and relapse 610    
Previously treated, excluding relapses 38    
Total cases notified 648    
Among 610 new and relapse cases:
48 (8%) cases aged under 15 years; male:female ratio: 1.1
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 437 (142%) 26 (60%) 523
Laboratory-confirmed RR-/MDR-TB cases     9
Patients started on MDR-TB treatment     8
TB/HIV 2013 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 83
Previously treated cases, excluding relapse, registered in 2012 73
HIV-positive TB cases, all types, registered in 2012  
RR-/MDR-TB cases started on second-line treatment in 2011 75
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2014  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-05-25 Data: www.who.int/tb/data